T3	Effect 27 36	myoclonus
T5	Treatment 53 91	continuous i.v. infusion of dobutamine
T6	Subject 95 140	a patient with end-stage renal disease (ESRD)
T7	Sub-Disorder 110 140	end-stage renal disease (ESRD)
T8	Drug 81 91	dobutamine
T9	Route 69 77	infusion
T4	Adverse_event 37 52	associated with
E1	Adverse_event:T4 
